Acquisition Speculation Fuels Viking Therapeutics Stock Surge
11.10.2025 - 20:27:05 | boerse-global.de
Shares of Viking Therapeutics experienced significant upward momentum, climbing 8.1% to reach $33.90 amid renewed market speculation about potential acquisition activity in the obesity treatment sector. Investor enthusiasm was clearly demonstrated through trading volume that surged 47% above average levels, reaching 4.4 million shares.
The biotech firm has demonstrated impressive performance in recent weeks, accumulating gains exceeding 15% and hitting an intraday peak of $35.45 during the latest session. This upward movement has elevated the company’s market capitalization to approximately $3.8 billion as market participants position themselves ahead of the scheduled October 22 release of third-quarter financial results.
Recent strategic moves within the pharmaceutical industry have intensified acquisition discussions. Two substantial transactions have particularly captured market attention: Novo Nordisk’s $5.2 billion purchase of Akero Therapeutics and... Read more...
Hol dir jetzt den Wissensvorsprung der Aktien-Profis.
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt anmelden.
Für. Immer. Kostenlos
